CytomX Therapeutics Inc. (($CTMX)) has held its Q3 earnings call. Read on for the main highlights of the call. CytomX Therapeutics Inc. recently ...

Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Good afternoon, everyone. Thank you for standing by. Welcome to ...

CX-2051 Phase 1 data update on track for Q1 2026 - - CX-2051 Phase 1b CRC combination study with bevacizumab to start in Q1 2026 - - Positive CX-801 Phase 1 monotherapy biomarker data at SITC 2025 ...

That's right... the CarBuzz spy photo team has captured a Mazda test mule being put through its paces near the Japanese ...

Customer backlash to AI-powered vehicle scans this summer did not deter AI investments in the company’s customer service ...

Despite a significant drop in revenue, CytomX Therapeutics Inc (CTMX) advances its oncology pipeline with promising clinical ...

As Auburn searches for its next head coach, the Tigers could learn a thing or two from Vanderbilt and Clark Lea.

A recent report estimating the cost to address homelessness is being conflated with Mayor Monroe Nichols' proposal to use $25 ...

CallMiner, the global leader in AI-powered conversation intelligence and customer experience (CX) automation, announced the winners of the 2025 LISTEN Awards at its annual user co ...

Discover the top 3 undervalued Professional Services stocks for Friday, November 07 based on AAII’s Stock Grades.

This 2023 Winnebago Revel 4×4 on Bring a Trailer with 25,000 miles offers adventure-ready performance, premium comfort, and ...

Pfizer's Conor Riordan explains how the pharmaceutical giant uses Celonis across 200+ markets to drive toward 95% order ...